TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
+13.63%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.76B
AUM Growth
+$122M
(+4.6%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-6.75%
Top 10 Holdings %
Top 10 Hldgs %
38.62%
Holding
217
New
37
Increased
33
Reduced
47
Closed
5
Top Buys
| 1 |
Zoetis
ZTS
|
$17.5M |
| 2 |
Johnson & Johnson
JNJ
|
$14.4M |
| 3 |
Elevance Health
ELV
|
$8.36M |
| 4 |
Novo Nordisk
NVO
|
$7.83M |
| 5 |
Thermo Fisher Scientific
TMO
|
$6.76M |
Top Sells
| 1 |
Merck
MRK
|
$45.3M |
| 2 |
Pfizer
PFE
|
$44.3M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$33.4M |
| 4 |
UnitedHealth
UNH
|
$21.5M |
| 5 |
Eli Lilly
LLY
|
$18.6M |
Sector Composition
| 1 | Healthcare | 93.74% |
| 2 | Real Estate | 2.75% |
| 3 | Financials | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Neurocrine Biosciences
NBIX
$14.3B
| $26.1M | 0.95% |
212,630
-57,139
| -21% | -$7.03M |
|
27
Idexx Laboratories
IDXX
$51.4B
| $25.6M | 0.93% |
102,403
-27,205
| -21% | -$6.79M |
|
28
Centene
CNC
$14.2B
| $24.2M | 0.88% |
333,738
-35,900
| -10% | -$2.6M |
|
|
29
Eli Lilly
LLY
$652B
| $23.2M | 0.84% |
216,442
-173,666
| -45% | -$18.6M |
|
30
Humana
HUM
$37B
| $23.2M | 0.84% |
68,487
-36,566
| -35% | -$12.4M |
|
31
Danaher
DHR
$143B
| $22.8M | 0.83% |
236,170
+18,612
| +9% | +$1.79M |
|
32
Bristol-Myers Squibb
BMY
$96B
| $22.7M | 0.82% |
366,064
-284,966
| -44% | -$17.7M |
|
|
SGEN
33
DELISTED
Seagen Inc. Common Stock
SGEN
| $21.5M | 0.78% |
279,417
| – | – |
|
|
34
Zoetis
ZTS
$67.9B
| $20.8M | 0.76% |
227,415
+191,655
| +536% | +$17.5M |
|
|
SAGE
35
DELISTED
Sage Therapeutics
SAGE
| $20.3M | 0.74% |
143,614
| – | – |
|
36
Teva Pharmaceuticals
TEVA
$21.7B
| $20.1M | 0.73% |
932,948
-150,895
| -14% | -$3.25M |
|
37
Omega Healthcare
OHI
$12.7B
| $19M | 0.69% |
579,785
| – | – |
|
38
Jazz Pharmaceuticals
JAZZ
$7.86B
| $18.6M | 0.67% |
110,452
| – | – |
|
|
ENDP
39
DELISTED
Endo International plc
ENDP
| $17.2M | 0.62% |
1,019,048
-59,366
| -6% | -$999K |
|
40
Boston Scientific
BSX
$159B
| $17.1M | 0.62% |
444,991
-12,594
| -3% | -$485K |
|
|
AET
41
DELISTED
Aetna Inc
AET
| $17M | 0.62% |
83,637
-13,485
| -14% | -$2.74M |
|
42
Sabra Healthcare REIT
SBRA
$4.56B
| $16.8M | 0.61% |
724,606
| – | – |
|
43
Becton Dickinson
BDX
$55.1B
| $16.8M | 0.61% |
65,782
+11,480
| +21% | +$2.92M |
|
44
Zimmer Biomet
ZBH
$20.9B
| $15.6M | 0.57% |
122,411
| – | – |
|
|
ONC
45
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $14.8M | 0.54% |
85,755
+30,970
| +57% | +$5.33M |
|
|
46
Novo Nordisk
NVO
$245B
| $14.2M | 0.52% |
603,800
+332,000
| +122% | +$7.83M |
|
47
Intuitive Surgical
ISRG
$167B
| $14.1M | 0.51% |
73,887
+3,450
| +5% | +$660K |
|
48
BioMarin Pharmaceuticals
BMRN
$11.1B
| $13.6M | 0.49% |
140,538
| – | – |
|
49
Edwards Lifesciences
EW
$47.5B
| $13.4M | 0.48% |
230,088
+31,263
| +16% | +$1.81M |
|
50
Nektar Therapeutics
NKTR
$764M
| $13M | 0.47% |
14,165
+1,580
| +13% | +$1.44M |
|